Matthew Call, in Mount Pleasant, UT - Marriage & Family Therapist

Matthew Call, is a Marriage & Family Therapist based in Mount Pleasant, Utah. Matthew Call is licensed to practice in Utah (license number 8846868-3904) and his current practice location is 18750 N 6750 E, Mount Pleasant, Utah. He can be reached at his office (for appointments etc.) via phone at (435) 462-5491.

NPI number for Matthew Call is 1073934881 and his current mailing address is 619 N 500 W, Provo, Utah. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1073934881.

Contact Information

	Matthew Call,
	18750 N 6750 E, Mount Pleasant, UT 84647-2309
	(435) 462-5491
	(435) 462-5492

Healthcare Provider's Profile

Full Name	Matthew Call
Gender	Male
Speciality	Marriage & Family Therapist
Location	18750 N 6750 E, Mount Pleasant, Utah
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1073934881
Provider Enumeration Date: 12/20/2013
Last Update Date: 12/20/2013

Medical Identifiers

Medical identifiers for Matthew Call such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1073934881	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
106H00000X	Marriage & Family Therapist	8846868-3904 (Utah)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Matthew Call is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Matthew Call, 619 N 500 W, Provo, UT 84601-1547 Ph: (801) 375-4240	Matthew Call, 18750 N 6750 E, Mount Pleasant, UT 84647-2309 Ph: (435) 462-5491

News Archive

Third-quarter fiscal 2010 results announced by Clinical Data

Clinical Data, Inc. (NASDAQ: CLDA) today announced the Company's operational and financial results for its third fiscal quarter ended December 31, 2009, confirming its plans to submit a new drug application (NDA) for vilazodone for the treatment of depression this quarter.

Researchers identify critical mechanisms of epigenetic cell programming

A team of researchers at the IRCM, supervised by Dr. Jacques Drouin, reprogrammed the identity of cells in the pituitary gland and identified critical mechanisms of epigenetic cell programming.

Experts paint a depressing future for Australian diabetics

New research presented at an international conference has predicted that almost a third of Australians with diabetes will die from the disease in the next decade.

Researchers are closer to developing fast, flexible, and powerful bioelectronic devices

Dion Khodagholy, assistant professor of electrical engineering, is focused on developing bioelectronic devices that are not only fast, sensitive, biocompatible, soft, and flexible, but also have long-term stability in physiological environments such as the human body.

TSRI scientists elucidate how Zika virus attacks the brains of newborns

In a study that could one day help eliminate the tragic birth defects caused by Zika virus, scientists from the Florida campus of The Scripps Research Institute have elucidated how the virus attacks the brains of newborns, information that could accelerate the development of treatments.

Matthew Call, - Couples Therapy in Mount Pleasant, UT